CASP3 and common variable immunodeficiency: To study whether observed differences in stimulated B cell survival from controls and CVID patients were due to distinctive apoptosis modulation, we evaluated stimulation-induced Caspase-3 activation and changes in viable and apoptotic CD27– or CD27+ B cell percentages (Fig. 2).